ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2016

T-Cell Therapy Using Interleukin-21-Primed Cytotoxic T-Cell Lymphocytes Combined With Cytotoxic T-Cell Lymphocyte Antigen-4 Blockade Results in Long-Term Cell Persistence and Durable Tumor Regression.

Aude G Chapuis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.